anti-CD24 monoclonal antibodies (Tel Aviv Sourasky Medical Center)

N/A

Report date: 2025/03/14 16:25:08

Base Information

Drug Nameanti-CD24 monoclonal antibodies (Tel Aviv Sourasky Medical Center)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionSignal transducer CD24 inhibitors
TargetsSignal transducer CD24
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTel-Aviv Sourasky Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesRamot At Tel Aviv UniversityTel-Aviv Sourasky Medical Center
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A